Abstract
Active hexose correlated compound (AHCC) is a mixture of polysaccharides, amino acids, lipids and minerals derived from cocultured mycelia of several species of Basidiomycete mushrooms. AHCC has been implicated to modulate immune functions and plays a protective role against infection. However, the potential role of AHCC in tumor immune surveillance is unknown. In this study, C57BL/6 mice were orally administered AHCC or water, followed by tumor cell inoculation. We showed that compared to pure water-treated mice, AHCC treatment significantly delayed tumor development after inoculation of either melanoma cell line B16F0 or lymphoma cell line EL4. Treatment with AHCC enhanced both Ag-specific activation and proliferation of CD4+ and CD8+ T cells, increased the number of tumor Ag-specific CD8+ T cells, and more importantly, increased the frequency of tumor Ag-specific IFN-γ producing CD8+ T cells. Interestingly, AHCC treatment also showed increased cell number of NK and γδ T cells, indicating the role of AHCC in activating these innate-like lymphocytes. In summary, our results demonstrate that AHCC can enhance tumor immune surveillance through regulating both innate and adaptive immune responses.
Similar content being viewed by others
Abbreviations
- CFSE:
-
5-(and –6) Carboxyfluorescein diacetate, succinimidyl ester
- AHCC:
-
Active hexose correlated compound
References
Wakame K (1999) Protective effects of active hexose correlated compound (AHCC) on the onset of diabetes induced by Streptozotocin in the rat. Biomed Res 20:145–152
Ghoneum M, Wimbley M, Salem F, Mcklain A, Attallah N, Gill G (1995) Immunomodulatory and anticancer effects of active hemicellulose compound (AHCC). Int J Immunother 11:23–28
Kidd PM (2000) The use of mushroom glucans and proteoglycans in cancer treatment. Altern Med Rev 5:4–27
Sun B, Wakame K, Mukoda T, Toyoshima A, Kana-zawa T, Kosuna K (1997) Protective effects of AHCC on carbon tetrachloride induced liver injury in mice. Nat Med 51:310–315
Burikhanov RB, Wakame K, Igarashi Y, Wang S, Matsuzaki S (2000) Suppressive effect of active hexose correlated compound (AHCC) on thymic apoptosis induced by dexamethasone in the rat. Endocr Regul 34:181–188
Shuyi Wang, Ichimura K, Wakame K (2001) Preventive effects of active hexose correlated compound (AHCC) on oxidative stress induced by ferric nitrilotriacetate in the Rat. Dokkyo J Med Sci 28:745–752
Ye SF, Wakame K, Ichimura K, Matsuzaki S (2004) Amelioration by active hexose correlated compound of endocrine disturbances induced by oxidative stress in the rat. Endocr Regul 38:7–13
Matsushita K, Kuramitsu Y, OhiroY, Obara M, Kobayashi M, Li YQ, Hosokawa M (1998) Combination therapy of active hexose correlated compound plus UFT significantly reduces the metastasis of rat mammary adenocarcinoma. Anticancer Drugs 9:343–350
Mamdooh G, Phyllis P, Yasuo N, Mabrouk G, Gus G (1992) Enhancement of NK cell activity in cancer patients by active hemicellulose compound (AHCC). In: Adjuvant Nutrition in Cancer Treatment Symposium, Tulsa, OK
Yagita A, Matsuzaki S, Wakasugi S, Sukegawa Y (2002) H-2 haplotype-dependent serum IL-12 production in tumor-bearing mice treated with various mycelial extracts. In Vivo 16:49–54
Ye SF, Ichimura K, Wakame K, Ohe M (2003) Suppressive effects of active hexose correlated compound on the increased activity of hepatic and renal ornithine decarboxylase induced by oxidative stress. Life Sci 74:593–602
Aviles H, Belay T, Vance M, Sun B, Sonnenfeld G (2004) Active hexose correlated compound enhances the immune function of mice in the hindlimb-unloading model of spaceflight conditions. J Appl Physiol 97:1437–1444
Shankaran V, Ikeda H, Bruce AT, White JM, Swanson PE, Old LJ, Schreiber RD (2001) IFN gamma and lymphocytes prevent primary tumour development and shape tumour immunogenicity. Nature 410:1107–1111
Gao Y, Yang W, Pan M, Scully E, Girardi M, Augenlicht LH, Craft J, Yin Z (2003) Gamma delta T cells provide an early source of interferon gamma in tumor immunity. J Exp Med 198:433–442
Hanson HL, Donermeyer DL, Ikeda H, White JM, Shankaran V, Old LJ, Shiku H, Schreiber RD, Allen PM (2000) Eradication of established tumors by CD8+ T cell adoptive immunotherapy. Immunity 13:265–276
Dobrzanski MJ, Reome JB, Dutton RW (1999) Therapeutic effects of tumor-reactive type 1 and type 2 CD8+ T cell subpopulations in established pulmonary metastases. J Immunol 162:6671–6680
Strome SE, Voss S, Wilcox R, Wakefield TL, Tamada K, Flies D, Chapoval A, Lu J, Kasperbauer JL, Padley D, Vile R, Gastineau D, Wettstein P, Chen L (2002) Strategies for antigen loading of dendritic cells to enhance the antitumor immune response. Cancer Res 62:1884–1889
Yin Z, Zhang DH, Welte T, Bahtiyar G, Jung S, Liu L, Fu XY, Ray A, Craft J (2000) Dominance of IL-12 over IL-4 in gamma delta T cell differentiation leads to default production of IFN-gamma: failure to down-regulate IL-12 receptor beta 2-chain expression. J Immunol 164:3056–3064
Gao Y, Tao J, Li MO, Zhang D, Chi H, Henegariu O, Kacch SM, Davis RJ, Flavell RA, Yin Z (2005) JNK1 is essential for CD8+ T cell-mediated tumor immune surveillance. J Immunol 175(9):5783–5789
Gorelik L, Flavell RA (2001) Immune-mediated eradication of tumors through the blockade of transforming growth factor-beta signaling in T cells. Nat Med 7:1118–1122
Ikeda H, Old LJ, Schreiber RD (2002) The roles of IFN gamma in protection against tumor development and cancer immunoediting. Cytokine Growth Factor Rev 13:95–109
deVere White RW, Hackman RM, Soares SE, Beckett LA, Li Y, Sun B (2004) Effects of a genistein-rich extract on PSA levels in men with a history of prostate cancer Urology 63:259–263
deVere White RW, Hackman RM, Soares SE, Beckett LA, Sun B (2002) Effects of a mushroom mycelium extract on the treatment of prostate cancer. Urology 60:640–644
Dunn GP, Old LJ, Schreiber RD, Bruce AT, Ikeda H (2004) The immunobiology of cancer immunosurveillance and immunoediting. Immunity 21:137–148
Shankaran V, Ikeda H, Bruce AT, White JM, Swanson PE, Old LJ Schreiber RD (2001) IFNgamma and lymphocytes prevent primary tumour development and shape tumour immunogenicity. Nature 410:1107–1111
Carding SR, Egan PJ (2002) Gammadelta T cells: functional plasticity and heterogeneity. Nat Rev Immunol 2:336–345
Yin Z, Chen C, Szabo SJ, Glimcher LJ, Ray A, Craft J (2002) T-Bet expression and failure of GATA-3 cross-regulation lead to default production of IFN-gamma by gammadelta T cells. J Immunol 168:1566–1571
Ghoneum M, NY, Torabi M, Gill G, Wojdani A (1992) Active hemicellulose compound (AHCC) enhance NK cell activity of aged mice in vivo. FASEB J 6:A1213 (Abstract)
Acknowledgements
We thank Dr. Kim Bottomly from Yale Immunobiology for providing C57BL/6 OT-1 and OT-II transgenic mice. We thank Dr. Fotios Koumpouras and Dr. Bohdan Harvey for critical review of the manuscript. This work was supported by an Arthritis Foundation Investigator Award, NIH (NIAMS) K01 AR 02188 and NIH (NIAID) R01 (R01 AI56219) grant (Z.Y.), and partially supported by the Amino Up, Japan (Z.Y). D.Z. is supported by National Science Foundation of China (No. 30471593), Shanghai Leading Academic Discipline Project (T 0206). Authors from Yale have no financial conflict of interest.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Gao, Y., Zhang, D., Sun, B. et al. Active hexose correlated compound enhances tumor surveillance through regulating both innate and adaptive immune responses. Cancer Immunol Immunother 55, 1258–1266 (2006). https://doi.org/10.1007/s00262-005-0111-9
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00262-005-0111-9